Supplementary table S3 from A Phase I Trial of BKM120 (Buparlisib) in Combination with Fulvestrant in Postmenopausal Women with Estrogen Receptor–Positive Metastatic Breast Cancer
收藏NIAID Data Ecosystem2026-05-09 收录
数据链接：
官方服务：
资源简介：
Supplementary Table S3. All observed coding mutations with detailed annotations
创建时间：
2016-04-01
